HuntING4 new tumor suppressors

Cell Cycle

Volumn 4, Issue 4, 2005, Pages 516-517

  Kim, Suwon ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; Contact inhibition; ING4; MYC; Tumor suppressor; Tumorigenesis

Indexed keywords

AGAR; ING 4 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

CANCER INHIBITION; CARCINOGENICITY; CELL CYCLE; CELL PROLIFERATION; CONTACT INHIBITION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; NONHUMAN; NUDE MOUSE; REGULATORY MECHANISM; SHORT SURVEY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

MUS MUSCULUS;

EID: 25444523243     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.4.1584     Document Type: Short Survey

References (20)

1. 1 cell-cycle control and cancer. Nature 2004; 432:298-306.
2. 1-phase progression. Genes Dev 1999; 13:1501-12.
3. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle reentry. Nature 2003; 424:223-8.
4. 1 phase of the cell cycle. Cell 1991; 67:293-302.
5. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-31.
6. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10.
7. Kim S, Chin K, Gray JW, Bishop JM. A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 2004; 101:16251-6.
8. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004; 428:328-32.
9. Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 2003; 63:2373-8.
10. 2 cells. FEBS Lett 2004; 570:7-12.
11. Aasland R, Gibson TJ, Stewart AF. The PHD finger: Implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 1995; 20:56-9.
12. Nelson PJ, Daniel TO. Emerging targets: Molecular mechanisms of cell contact-mediated growth control. Kidney Int 2002; 61:99-105.
13. Fagotto F, Gumbiner BM. Cell contact-dependent signaling. Dev Biol 1996; 180:445-454.
14. Birchmeier W, Behrens J. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasive ness. Biochim Biophys Acta 1994; 1198:11-26.
15. Ben-Ze'ev A. Cytoskeletal and adhesion proteins as tumor suppressors. Curr Opin Cell Biol 1997; 9:99-108.
16. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 1997; 8:1039-48.
17. Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 2001; 414:768-73.
18. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999; 19:1-11.
19. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79:315-28.
20. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88:277-85.